158 related articles for article (PubMed ID: 3878459)
21. Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG.
Peerschke EI; Ghebrehiwet B
Clin Immunol Immunopathol; 1992 Apr; 63(1):45-50. PubMed ID: 1591882
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
Wines BD; Easterbrook-Smith SB
Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
[TBL] [Abstract][Full Text] [Related]
23. The use of solid phase Clq and horseradish peroxidase-conjugated goat anti-IgG for the detection of immune complexes in human serum.
Wehler C; Andrews JM; Bing DH
Mol Immunol; 1981 Mar; 18(3):157-62. PubMed ID: 6973690
[No Abstract] [Full Text] [Related]
24. [A stable conformer of IgG, prepared by an acidic influence: study by calorimetry, binding of the C1q complement component, and monospecific anti-IgG].
Kravchuk ZI; Vlasov AP; Liakhnovich GV; Martsev SP
Biokhimiia; 1994 Oct; 59(10):1458-77. PubMed ID: 7819387
[TBL] [Abstract][Full Text] [Related]
25. The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane.
Bohnsack JF; Tenner AJ; Laurie GW; Kleinman HK; Martin GR; Brown EJ
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3824-8. PubMed ID: 2987948
[TBL] [Abstract][Full Text] [Related]
26. [Inhibition of the binding and activation of the first component of human complement. The effect of synthetic peptides, immunoglobulin fragments and various proteins].
Kozlov LV; Sizoĭ MN; Zinchenko AA; Levkovskiĭ AV
Biokhimiia; 1986 May; 51(5):707-18. PubMed ID: 3486677
[TBL] [Abstract][Full Text] [Related]
27. An immune complex selective affinity matrix utilizing a synthetic peptide.
Baumann MA; Anderson BE
J Biol Chem; 1990 Oct; 265(30):18414-22. PubMed ID: 2211709
[TBL] [Abstract][Full Text] [Related]
28. Evidence for arginine residues in the immunoglobulin-binding sites of human Clq.
Comis A; Easterbrook-Smith SB
Biochim Biophys Acta; 1985 Sep; 842(1):45-51. PubMed ID: 3876114
[TBL] [Abstract][Full Text] [Related]
29. A small domain (6.5 kDa) of bacterial protein G inhibits C3 covalent binding to the Fc region of IgG immune complexes.
Muñoz E; Vidarte L; Pastor C; Casado M; Vivanco F
Eur J Immunol; 1998 Aug; 28(8):2591-7. PubMed ID: 9710236
[TBL] [Abstract][Full Text] [Related]
30. Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice.
McDonald TL
Immunology; 1982 Feb; 45(2):365-70. PubMed ID: 6977483
[TBL] [Abstract][Full Text] [Related]
31. [Non-native conformational states of immunoglobulins: thermodynamic and functional analysis of rabbit IgG].
Vlasov AP; Kravchuk ZI; Martsev SP
Biokhimiia; 1996 Feb; 61(2):212-35. PubMed ID: 8717493
[TBL] [Abstract][Full Text] [Related]
32. C1q binding and C1q deviation assays using enzyme labelled C1q.
Smith GW; Myles MJ; Simpson IJ
J Immunol Methods; 1984 Feb; 67(1):167-72. PubMed ID: 6366065
[TBL] [Abstract][Full Text] [Related]
33. Comparative studies on biological activities of subcomponents C1q of the first component of human, bovine, mouse and guinea-pig complement.
Sasaki T; Yonemasu K
Biochim Biophys Acta; 1984 Mar; 785(3):118-22. PubMed ID: 6608375
[TBL] [Abstract][Full Text] [Related]
34. Requirements for the binding of human plasma fibronectin to the C1q subunit of the first component of complement.
Sorvillo J; Gigli I; Pearlstein E
J Immunol; 1983 Sep; 131(3):1400-4. PubMed ID: 6309962
[TBL] [Abstract][Full Text] [Related]
35. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
Clin Immunol Immunopathol; 1984 Jan; 30(1):104-16. PubMed ID: 6421520
[TBL] [Abstract][Full Text] [Related]
36. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
[TBL] [Abstract][Full Text] [Related]
37. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
38. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
[TBL] [Abstract][Full Text] [Related]
39. Circulating immune complexes in dogs with osteosarcoma.
Segal-Eiras A; Robins RA; Hannant D; Owen LN; Baldwin RW
Br J Cancer; 1982 Sep; 46(3):444-7. PubMed ID: 6982058
[No Abstract] [Full Text] [Related]
40. Binding of complement component C1q by rat adipocyte membranes.
Comis A; Easterbrook-Smith SB
Mol Immunol; 1985 Aug; 22(8):857-61. PubMed ID: 3876503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
